Sujay Kango
Insider Reports History
- Location
- Bridgewater, NJ
- Signature
- /s/ Adam M. Veness, as attorney-in-fact for Sujay Kango
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Sujay Kango:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 90,000 | 30 Mar 2022 | Direct | ||
| Dianthus Therapeutics, Inc. /DE/ | Director | Stock Option (Right to Buy) | 25,000 | 04 Mar 2025 | Direct | ||
| MEI Pharma, Inc. | Director | Stock Option (Right to Buy) | 10,000 | 29 Sep 2023 | Direct | ||
| ACCELERON PHARMA INC | EVP, Chief Commercial Officer | Common Stock | 0 | $29.37 | 19 Nov 2021 | Direct | |
| ACCELERON PHARMA INC | EVP, Chief Commercial Officer | Option to Purchase Common Stock | 0 | 19 Nov 2021 | Direct |